An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness

NCT05381454 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Respiratory Viral Infection
Antiviral Treatment
COVID-19

Interventions

DRUG: Mitoquinone/mitoquinol mesylate

Sponsor

University of California, Los Angeles